Document is current
Any future updates will be listed below
-
Authors
van der Arend, Britt W. H. http://orcid.org/0000-0001-8999-0087
van Casteren, Daphne S.
Verhagen, Iris E.
MaassenVanDenBrink, Antoinette
Terwindt, Gisela M.
-
Funding
Funding for this research was provided by:
Hersenstichting (HA2017.01.05)
ZonMw (849200007)
- License Information
-
More Information
Article History
Received: 19 October 2023
Accepted: 29 January 2024
First Online: 15 February 2024
Declarations
:
: The study is performed in accordance with the declaration of Helsinki Ethical Principles and Good Clinical Practices and was approved by the local and national ethics committees (NL67994.058.19).
: The authors declared the following potential conflicts of interest with respect to the research, authorship, and/or publication of this article: B.W.H. van der Arend, D.S. van Casteren, I.E. Verhagen, A. MaassenVanDenBrink and G.M. Terwindt report independent support from the Netherlands Organization for Health Research (849200007) and the Dutch Brain Foundation (HA2017.01.05). A. MaassenVanDenBrink reports consultancy or industry support from Novartis, Lillyand Teva, and Allergan/Abbvie and independent support from the Dutch Research Council (Vici grant) and the Dutch Heart Foundation. G.M. Terwindt reports consultancy or industry support from Novartis, Lilly and Teva, Allergan/Abbvie, and Lundbeck and independent support from the European Community, Dutch Heart Foundation, IRRF and Dioraphte.
